Most Recent Articles by Kathy Boltz, PhD
Multiple myeloma uses a trick akin to a wolf in sheep's clothing to grow in and spread to new bone sites.
ASCO 2015: 12-week dosing schedule of zoledronic acid is noninferior to a more-frequent schedule of every 4 weeks.
Magnetic resonance imaging (MRI) and near-infrared spectral tomography (NIRST) is feasible and more accurate than MRI alone
A single molecule appears to be the central regulator driving metastasis in prostate cancer.
An online registry that matches women with research studies and clinical trials enrolled study participants more quickly.
More Articles by Kathy Boltz, PhD
- Multiple myeloma uses "wolf in sheep's clothing" tactic to avoid immune response in bone
- Comparison of zoledronic acid dosing schedules finds less frequent schedule noninferior
- HPV16 detection after oropharyngeal cancer treatment may increase risk for recurrence
- Delayed referrals, diagnoses undermine cancer patients' faith in health care system
- Alcohol Consumption Linked with Less Disability in Chronic Pain
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|